← Back to Search

Balance Improvement Intervention for Vestibular Hypofunction (MINDGAPS Trial)

N/A
Recruiting
Research Sponsored by University of Montana
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Ability to stand independently
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 12 weeks
Awards & highlights

MINDGAPS Trial Summary

This trial will test a new intervention for improving vestibular function (balance) in older adults, to help prevent falls and other health problems.

Who is the study for?
This trial is for older adults who can stand on their own and have dizziness or balance problems due to vestibular hypofunction, confirmed by specific tests. It's not for those with blindness, neck spine disorders, certain artery issues, or eye movement problems caused by central nervous system dysfunction.Check my eligibility
What is being tested?
The study is testing a new intervention designed to improve vestibular function and reduce dizziness in older adults living in the community. The research will evaluate how well it works, its safety and feasibility, and whether people are likely to use it regularly.See study design
What are the potential side effects?
Since this is a pilot study focusing on a non-drug intervention for balance improvement, detailed side effects aren't specified but may include discomfort or increased dizziness during initial use of the system.

MINDGAPS Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I can stand up on my own.

MINDGAPS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Computerized Dynamic Visual Acuity (cDVA)
Secondary outcome measures
Activities-specific Balance Confidence Scale (ABC)
Dizziness Handicap Inventory (DHI)
Functional Gait Assessment (FGA)
+3 more
Other outcome measures
Community Ambulatory Task (CAT)
General Well Being Scale
Life Space Mobility Assessment (LSA)
+6 more

Find a Location

Who is running the clinical trial?

National Institute on Deafness and Other Communication Disorders (NIDCD)NIH
330 Previous Clinical Trials
178,435 Total Patients Enrolled
Johns Hopkins UniversityOTHER
2,262 Previous Clinical Trials
14,823,128 Total Patients Enrolled
University of MontanaLead Sponsor
23 Previous Clinical Trials
3,518 Total Patients Enrolled
1 Trials studying Vestibular Hypofunction
500 Patients Enrolled for Vestibular Hypofunction

Media Library

Novel Intervention System Clinical Trial Eligibility Overview. Trial Name: NCT05391932 — N/A
Vestibular Hypofunction Research Study Groups:
Vestibular Hypofunction Clinical Trial 2023: Novel Intervention System Highlights & Side Effects. Trial Name: NCT05391932 — N/A
Novel Intervention System 2023 Treatment Timeline for Medical Study. Trial Name: NCT05391932 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many subjects are being enlisted for this clinical experiment?

"Affirmative. From the information on clinicaltrials.gov, it appears that this medical trial is currently searching for participants. It was initially posted on May 11th 2022 and last edited a few days later on May 21st 2022. 36 individuals need to be enrolled from 1 location."

Answered by AI

Are any new volunteers still welcome to join this experiment?

"According to clinicaltrials.gov, this study is actively recruiting test subjects with the first posting occuring on May 11th 2022 and an update occurring ten days later."

Answered by AI
~12 spots leftby Mar 2025